Author

Myrella Vlenterie

Observed names: M Vlenterie, M. Vlenterie, MYRELLA VLENTERIE, Vlenterie, M.

Observed institutions: Royal Marsden NHS Foundation Trust, Radboud University Nijmegen, Gelre Hospitals, Radboud University Medical Center, The Netherlands Cancer Institute, Royal Marsden Hospital

ORCID: 0000-0002-4523-4084

Observed ORCID: 0000-0002-4523-4084

OpenAlex ID: A5012955112

Outcome of chemotherapy in advanced synovial sarcoma patients: Review of 15 clinical trials from the European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group; setting a new landmark for studies in this entity

2016 · Myrella Vlenterie, Saskia Litière, et al. · European Journal of Cancer · 158

Solitary fibrous tumor – clinicopathologic, immunohistochemical and molecular analysis of 28 cases

2014 · Rob JC Vogels, Myrella Vlenterie, et al. · Diagnostic Pathology · 120

PDF

Age as an independent prognostic factor for survival of localised synovial sarcoma patients

2015 · Myrella Vlenterie, Vincent K Y Ho, et al. · British Journal of Cancer · 106

PDF

Next generation sequencing in synovial sarcoma reveals novel gene mutations

2015 · Myrella Vlenterie, Melissa H.S. Hillebrandt-Roeffen, et al. · Oncotarget · 63

PDF

Expression and clinical relevance of MET and ALK in Ewing sarcomas

2013 · Emmy D.G. Fleuren, Melissa H.S. Roeffen, et al. · International Journal of Cancer · 61

PDF

Recent advances on anti-angiogenic multi-receptor tyrosine kinase inhibitors in osteosarcoma and Ewing sarcoma

2023 · Emmy D. G. Fleuren, Myrella Vlenterie, et al. · Frontiers in Oncology · 41

Pheochromocytoma and Gastrointestinal Stromal Tumors in Patients With Neurofibromatosis Type I

2013 · Myrella Vlenterie, Uta Flucke, et al. · The American Journal of Medicine · 39

Phosphoproteomic Profiling Reveals ALK and MET as Novel Actionable Targets across Synovial Sarcoma Subtypes

2017 · Emmy D.G. Fleuren, Myrella Vlenterie, et al. · Cancer Research · 38

PDF

Targeting Cyclin-Dependent Kinases in Synovial Sarcoma: Palbociclib as a Potential Treatment for Synovial Sarcoma Patients

2016 · Myrella Vlenterie, Melissa H. S. Hillebrandt-Roeffen, et al. · Annals of Surgical Oncology · 36

PDF

Anti-angiogenic therapy, a new player in the field of sarcoma treatment

2014 · Yvonne M.H. Versleijen-Jonkers, Myrella Vlenterie, et al. · Critical Reviews in Oncology/Hematology · 34

Prevalence, Impact, and Correlates of Severe Fatigue in Patients With Gastrointestinal Stromal Tumors

2016 · Hanneke Poort, Winette T.A. van der Graaf, et al. · Journal of Pain and Symptom Management · 32

PDF

Synovial sarcoma diagnosis and management in the era of targeted therapies

2015 · Myrella Vlenterie, Robin L. Jones, et al. · Current Opinion in Oncology · 30

Positron emission tomography response criteria in solid tumours criteria for quantitative analysis of [ 18 F]-fluorodeoxyglucose positron emission tomography with integrated computed tomography for treatment response assessment in metastasised solid tumours: All that glitters is not gold

2016 · Annelieke E.C.A.B. Willemsen, Myrella Vlenterie, et al. · European Journal of Cancer · 10

PDF

Fatal microscopic pulmonary tumour embolisms in patients with breast cancer: necessary knowledge for future medical practice.

2014 · M Vlenterie, I M E Desar, et al. · PubMed · 10

Early Metabolic Response as a Predictor of Treatment Outcome in Patients With Metastatic Soft Tissue Sarcomas

2019 · MYRELLA VLENTERIE, WIM JG OYEN, et al. · Anticancer Research · 9

PDF

Promising management of pazopanib-induced liver toxicity

2015 · Myrella Vlenterie, Nielka P. van Erp, et al. · Acta Oncologica · 9

PDF

Early metabolic response as predictor for treatment outcome of pazopanib in patients with metastatic soft tissue sarcomas (the PREDICT study).

2018 · Winette T.A. Van Der Graaf, Myrella Vlenterie, et al. · Journal of Clinical Oncology · 2

SusTained Employability in cancer Patients and their partnerS: Results of a Randomized Controlled Trial into the Effectiveness of the STEPS Program

2026 · Amber D. Zegers, Pieter Coenen, et al. · Journal of Occupational Rehabilitation

PDF

Cost-Effectiveness of the STEPS Work Participation Program Compared to Usual Care, for Cancer Survivors: An Economic Evaluation Alongside a Randomized Controlled Trial

2026 · Johanna M. van Dongen, Amber D. Zegers, et al. · Journal of Occupational Rehabilitation

PDF

Supplemental Table 5 from Phosphoproteomic Profiling Reveals ALK and MET as Novel Actionable Targets across Synovial Sarcoma Subtypes